Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRIW) FCF Margin (2020 - 2025)

Biofrontera has reported FCF Margin over the past 6 years, most recently at 14.12% for Q4 2025.

  • Quarterly results put FCF Margin at 14.12% for Q4 2025, down 634.0% from a year ago — trailing twelve months through Dec 2025 was 32.13% (down 459.0% YoY), and the annual figure for FY2025 was 32.14%, down 459.0%.
  • FCF Margin for Q4 2025 was 14.12% at Biofrontera, up from 54.15% in the prior quarter.
  • Over the last five years, FCF Margin for BFRIW hit a ceiling of 2.11% in Q2 2022 and a floor of 229.05% in Q4 2021.
  • Median FCF Margin over the past 5 years was 42.64% (2023), compared with a mean of 59.31%.
  • Biggest five-year swings in FCF Margin: plummeted -22095bps in 2021 and later surged 14749bps in 2022.
  • Biofrontera's FCF Margin stood at 229.05% in 2021, then skyrocketed by 64bps to 81.56% in 2022, then fell by -3bps to 83.64% in 2023, then skyrocketed by 91bps to 7.78% in 2024, then tumbled by -81bps to 14.12% in 2025.
  • The last three reported values for FCF Margin were 14.12% (Q4 2025), 54.15% (Q3 2025), and 34.34% (Q2 2025) per Business Quant data.